News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,582 Results
Type
Article (8017)
Company Profile (142)
Press Release (478422)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166714)
Career Advice (303)
Deals (25738)
Drug Delivery (7)
Drug Development (52796)
Employer Resources (14)
FDA (9749)
Job Trends (8570)
News (238058)
Policy (17881)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (492)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (99)
Alliances (33157)
ALS (114)
Alzheimer's disease (990)
Antibody-drug conjugate (ADC) (291)
Approvals (10432)
Artificial intelligence (344)
ASCO (160)
Autoimmune disease (227)
Automation (30)
Bankruptcy (263)
Belgium (3)
Best Places to Work (6958)
BIO (36)
Biologics (14)
BIOSECURE Act (1)
Biosimilars (119)
BioSpace Insights (17)
Biotechnology (90)
Bispecific (2)
Bladder cancer (140)
Brain cancer (33)
Breast cancer (522)
Cancer (3824)
Cardiovascular disease (230)
Career advice (245)
Career pathing (1)
CAR-T (181)
CDC (1)
CDMO (21)
Celiac Disease (1)
Cell therapy (496)
Cervical cancer (35)
Clinical research (48156)
Collaboration (1305)
Commercialization (5)
Compensation (1547)
Complete response letters (35)
COVID-19 (764)
CRISPR (64)
C-suite (820)
Cystic fibrosis (87)
Data (5982)
Denatured (4)
Depression (108)
Dermatology (79)
Diabetes (363)
Diagnostics (4229)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (161)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (171)
Earnings (73775)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88246)
Executive appointments (721)
FDA (12556)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (969)
Gene editing (126)
Generative AI (11)
Gene therapy (339)
GLP-1 (298)
Government (948)
Grass and pollen (2)
Guidances (282)
Healthcare (9369)
Hematology (94)
HIV (55)
Huntington's disease (23)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (70)
Immunology and inflammation (110)
Immuno-oncology (62)
Indications (168)
Infectious disease (957)
Inflammatory bowel disease (131)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (266)
Interviews (41)
IPO (12389)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (17)
Kidney disease (46)
Layoffs (59)
Legal (5195)
Licensing (24)
Liver cancer (46)
Longevity (20)
Lung cancer (554)
Lymphoma (261)
Machine learning (29)
Management (3)
Manufacturing (589)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8693)
Medtech (8856)
Mergers & acquisitions (14422)
Metabolic disorders (738)
mRNA (69)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (229)
Neuropsychiatric disorders (40)
Neuroscience (1889)
NextGen: Class of 2026 (3150)
Non-profit (843)
Obesity (235)
Opinion (10)
Ovarian cancer (165)
Pain (179)
Pancreatic cancer (212)
Parkinson's disease (208)
Partnered (12)
Patents (509)
Patient recruitment (534)
Patient selection (13)
Peanut (33)
People (41414)
Peptides (4)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15543)
Phase 2 (21505)
Phase 3 (14513)
Pipeline (7937)
Policy (18)
Postmarket research (1570)
Preclinical (6565)
Press Release (34)
Prostate cancer (196)
Psychedelics (9)
Radiopharmaceuticals (198)
Rare diseases (600)
Real estate (3024)
Recruiting (6)
Regenerative medicine (7)
Regulatory (15048)
Reports (23)
Research institute (586)
Resumes & cover letters (45)
Rett syndrome (44)
RNA editing (7)
RSV (48)
Schizophrenia (104)
Series A (169)
Series B (125)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (91)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (51)
Vaccines (336)
Venture capital (17)
Weight loss (75)
Women's health (91)
Date
Today (93)
Last 7 days (342)
Last 30 days (1552)
Last 365 days (19111)
2026 (14209)
2025 (19251)
2024 (22987)
2023 (26538)
2022 (34586)
2021 (37167)
2020 (33471)
2019 (23256)
2018 (17460)
2017 (18745)
2016 (17918)
2015 (24247)
2014 (21675)
2013 (18135)
2012 (20221)
2011 (20427)
2010 (20332)
Location
Africa (229)
Alabama (80)
Alaska (2)
Arizona (313)
Arkansas (11)
Asia (17993)
Australia (2110)
California (12507)
Canada (3282)
China (556)
Colorado (507)
Connecticut (434)
Delaware (218)
Europe (24723)
Florida (1880)
Georgia (395)
Hawaii (3)
Idaho (46)
Illinois (740)
India (55)
Indiana (326)
Iowa (16)
Japan (435)
Kansas (104)
Kentucky (33)
Louisiana (27)
Maine (26)
Maryland (1242)
Massachusetts (8183)
Michigan (315)
Minnesota (577)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (125)
New Hampshire (60)
New Jersey (2743)
New Mexico (12)
New York (2934)
North Carolina (1325)
North Dakota (4)
Northern California (6293)
Ohio (298)
Oklahoma (14)
Oregon (16)
Pennsylvania (2327)
Puerto Rico (24)
Rhode Island (30)
South America (407)
South Carolina (78)
South Dakota (1)
Southern California (5216)
Tennessee (125)
Texas (2051)
United States (40530)
Utah (377)
Vermont (1)
Virginia (160)
Washington D.C. (39)
Washington State (965)
West Virginia (1)
Wisconsin (78)
Wyoming (1)
486,582 Results for "cardiofocus inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CardioFocus Announces Late-Breaking Data at AF Symposium 2026 and Expands Pulsed Field Ablation Clinical Programs
February 4, 2026
·
3 min read
Press Releases
Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias
October 14, 2025
·
4 min read
Press Releases
CardioFocus to Showcase PFA Portfolio at Heart Rhythm 2025
April 23, 2025
·
2 min read
Deals
CardioFocus Acquires Electrophysiology Division of Galvanize Therapeutics
CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, announced the acquisition of Galvanize Therapeutics’ Electrophysiology Technology division.
January 11, 2024
·
2 min read
Press Releases
CardioFocus Announces Successful Clinical Cases with QuickShot™ Nav Large Area Focal PFA Catheter
April 17, 2025
·
2 min read
Press Releases
CardioFocus Announces First Patients Treated with OptiShot™ Pulsed Field Ablation System
December 17, 2024
·
2 min read
Genetown
CardioFocus Announces Pulsed Field Ablation Milestones
CardioFocus, Inc. announced several milestones toward the development of a next generation pulse field ablation technology for treatment of AFib, including the formation of a clinical advisory board, filing of key patents and completing initial pre-clinical studies.
July 19, 2022
·
6 min read
Business
CardioFocus Appoints Stephan Ogilvie as Chief Financial Officer
CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the appointment of Stephan Ogilvie as its Chief Financial Officer.
June 29, 2021
·
3 min read
Genetown
CardioFocus Announces 10,000 Patients Treated Worldwide
CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation, announced that more than 10,000 patients worldwide have been treated with the HeartLight® Endoscopic Ablation System.
December 15, 2020
·
4 min read
Policy
CardioFocus Receives Regulatory Approval to Market HeartLight X3 System in Japan
CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced that the Japanese Ministry of Health, Labor and Welfare (“MHLW”) has approved the company’s HeartLight X3 System for marketing in Japan.
June 23, 2021
·
4 min read
1 of 48,659
Next
